semaglutide competitors Canada approves first generic version of Ozempic amid rising GLP-1 competition Wegovy's price cut, Amgen's Ozempic

Bacteriostatic water contains a preservative

Food and Drug Administration for use in adults 18 and older who have a body mass index (BMI) of 25 or more

While there are varying perspectives on this issue, in a viewpoint that I was pleased to co-author with Sam Klein and Kevin Hall just published in JAMA, we suggest that the concern regarding physical frailty or sarcopenia with GLP-1-based medications may not be as grounded as some argue

Clinically meaningful interactions would not be expected with other sulfonylureas (e.g., glipizide, tolbutamide, and glimepiride) which, like glyburide, are primarily eliminated by CYP2C9 [see Warnings and Precautions]